WHO ICTRP trial

A Study to Evaluate the Long-Term Safety of Astegolimab in Patients with Chronic…

CTIS2022-502501-15-00 · EU Clinical Trials Information System · Recruiting

Key facts

Trial ID CTIS2022-502501-15-00
Public title A Study to Evaluate the Long-Term Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease
Scientific title A Phase III Open-Label Extension Study to Evaluate the Long-Term Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease - GB43374
Primary sponsor F. Hoffmann-La Roche AG
Registry EU Clinical Trials Information System
Recruitment status Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): No
Countries Israel;New Zealand;United States;South Africa;Mexico;Canada;Hong Kong;Argentina;Australia;United Kingdom;Korea, Republic…
Conditions Chronic Obstructive Pulmonary Disease (COPD) MedDRA version: 21.1Level: PTClassification code: 10009033Term: Chronic obstructive pulmonary disease Class: 100000004855;Therapeutic area: Health Care [N] - Environment and Public Health…
Interventions Product Name: ASTEGOLIMAB, Product Code:PRD10151603, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: SALMETEROL, Product Code:SUB10430MIG, Pharmaceutical Form: INHALATION POWDER, Other…
Registration date May 30, 2023
Target size 1668
Registry page euclinicaltrials.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations